News Sentiment

RLYB sentiment intelligence

Rallybio Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 53 Balanced news tone 51 relevant articles

Exchange NASDAQ United States

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 15.73 Week of 10 Jul 2026

Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Deals and strategy

74/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-0.5% over one week, -1.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Rallybio Corporation (NASDAQ: RLYB) to merge and rebrand as Avenzo Therapeutics

Market Reaction

Balanced read

50/100 confidence

Primary event Deals and strategy 74/100 classification

One-week reaction -0.5% Price digesting

Trend fit Trend active -1.2% over four weeks

Fair value 29.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 13

Neutral 32

Negative 6

Relevance

Why the article matched

Direct first

Direct company coverage 43

Industry context 8

Sector context 0

Sources

Coverage mix

Publishers

Stock Titan 9

Market source 7

TradingView 4

Investing.com 4

TradingKey 3

Business Wire 2

Quiver Quantitative 2

simplywall.st 2

Event Lens

What the news is about

Classified themes

Deals and strategy 20

Market update 17

Earnings 12

Regulatory and legal 1

Analyst action 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-51 of 51

Investing.com Direct company coverage

Adar1 Capital Management buys $1.11m of Rallybio (RLYB) stock

Adar1 Capital Management, LLC and Daniel Schneeberger, who together own over 10% of Rallybio Corp (NASDAQ:RLYB), purchased more than $1.11 million worth of the company's common stock. These insider purchases, occurring on May 13 and May 15, 2026, were made at prices ranging from

Tone: Positive 63/100
Event: Market update
Published: 16 May 2026 22:13
Source: Investing.com

Quiver Quantitative Direct company coverage

Insider Stock Purchases: May 16, 2026

The article summarizes significant insider stock purchases reported on May 16, 2026, highlighting transactions for companies like RALLYBIO CORP ($RLYB), ALPHA METALLURGICAL RESOURCES, INC. ($AMR), KBR, INC. ($KBR), DUTCH BROS INC. ($BROS), and GPGI, INC. It details the number of

Tone: Positive 72/100
Event: Market update
Published: 16 May 2026 21:40
Source: Quiver Quantitative

Stock Titan Direct company coverage

ADAR1 funds boost Rallybio (RLYB) stake with May open-market buys

ADAR1 Capital Management, LLC and Daniel Schneeberger reported significant open-market purchases of Rallybio Corp (RLYB) common stock in May 2026. The entities acquired a total of 79,559 shares across several transactions, with prices ranging from $13.77 to $14.00 per share. Thes

Tone: Positive 73/100
Event: Deals and strategy
Published: 16 May 2026 01:10
Source: Stock Titan

Stock Titan Direct company coverage

Viking Global Group (RLYB) discloses 528,954 shares, 9.99% stake

Viking Global-related reporting persons have disclosed a 9.99% stake in Rallybio Corporation (RLYB), totaling 528,954 shares. This includes 524,347 directly owned shares and 4,607 shares from Warrants, with the total beneficial ownership capped at 9.99% due to a contractual "Bloc

Tone: Neutral 50/100
Event: Deals and strategy
Published: 15 May 2026 22:11
Source: Stock Titan